Author(s):
Siswandi1, Simanjuntak Lamhot Burju, Putra Berry Harsono, Suhendra Gugun, Muhammad Arif Rizki Saputra, Haafizah Dania, Adnan, Lalu Muhammad Irham, Imaniar Noor Faridah, Dyah Aryani Perwitasari
Email(s):
dyah.perwitasari@pharm.uad.ac.id
DOI:
10.52711/0974-360X.2025.00117 
Address:
Siswandi1, Simanjuntak Lamhot Burju1, Putra Berry Harsono1, Suhendra Gugun1, Muhammad Arif Rizki Saputra2, Haafizah Dania2, Adnan2, Lalu Muhammad Irham2, Imaniar Noor Faridah2, Dyah Aryani Perwitasari2*
1RSPAU dr. Suhardi Hardjolukito, Yogyakarta, Indonesia.
2Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2025
ABSTRACT:
To date, cancer remains as a burdensome disease in Indonesia. Therapies for cancer patients require long periods of time, with the likelihood of the patients experiencing post-chemotherapy side effects and may affect the patients’ quality of life. The aim of this research was to descriptively compare the quality of life of cancer patients using the Indonesian version of the 5-level EuroQoL-5 Dimension (EQ-5D-5L) and the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30). This research was conducted using a cross-sectional research design at a hospital in Yogyakarta, Indonesia from July to August 2022. The inclusion criterion was adult cancer patients undergoing a chemotherapy at the hospital during the research period. Meanwhile, the exclusion criterion was patients unwilling to participate in the research. The questionnaires used in this research were the EQ-5D-5L and the EORTC QLQ-C30. As many as 101 subjects with a mean utility score of 0.63 and a visual analogue scale (VAS) score of 75.33 based on the EQ-5D-5L were involved. Approximately 10%–20% of the subjects expressed having problems in all functions on the EQ-5D-5L. Based on the EORTC QLQ-C30, all functions scored between 80% and 91%, with the global health score being very low (26.90%). Based on the results, there was a convergence in worsening functions and symptoms experienced by cancer patients in this research. Pain and depressive symptoms require special attention from healthcare service providers in order for patients’ overall quality of life to increase.
Cite this article:
Siswandi1, Simanjuntak Lamhot Burju, Putra Berry Harsono, Suhendra Gugun, Muhammad Arif Rizki Saputra, Haafizah Dania, Adnan, Lalu Muhammad Irham, Imaniar Noor Faridah, Dyah Aryani Perwitasari. Quality of Life of Cancer patients Measured with the 5-Level EuroQoL-5 Dimension (EQ-5D-5L) and the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30). Research Journal of Pharmacy and Technology.2025;18(2):792-6. doi: 10.52711/0974-360X.2025.00117
Cite(Electronic):
Siswandi1, Simanjuntak Lamhot Burju, Putra Berry Harsono, Suhendra Gugun, Muhammad Arif Rizki Saputra, Haafizah Dania, Adnan, Lalu Muhammad Irham, Imaniar Noor Faridah, Dyah Aryani Perwitasari. Quality of Life of Cancer patients Measured with the 5-Level EuroQoL-5 Dimension (EQ-5D-5L) and the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30). Research Journal of Pharmacy and Technology.2025;18(2):792-6. doi: 10.52711/0974-360X.2025.00117 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-2-49
REFERENCES:
1. Globocan. Indonesia. Globocan 2020 [Internet]. 2020 [cited 2022 Jun 5]; Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf
2. Lewandowska A. Rudzki G. Lewandowski T, Próchnicki M, Rudzki S, Laskowska B, et al. Quality of Life of Cancer Patients Treated with Chemotherapy. Int J Environ Res Public Health. 2020; 17(19). doi.org/ 10.3390/ijerph17196938.
3. Sivabalan R. A study to evaluate the Quality of life in Head and Neck Cancer Patients admitted in Pravara Rural Hospital, Loni (Bk). Asian J Nur Edu Res. 2013; 3(1): 21–4.
4. Bang H. Yeun E. Kim H. The Quality of Life and Fatigue of Gastric Cancer Patients. Res J Pharm Tech. 2019; 12(7): 3289–94. doi.org/ 10.5958/0974-360X.2019.00545.6
5. Abegaz TM. Ayele AA. Gebresillassie BM. Health Related Quality of Life of Cancer Patients in Ethiopia. J Oncol. 2018; 2018: 1467595. doi.org/10.1155/2018/1467595
6. Jitender S. Mahajan R. Rathore V. Choudhary R. Quality of life of cancer patients. J Exp Ther Oncol. 2018;12(3):217–21.
7. Sibhat SG. Fenta TG. Sander B. Gebretekle GB. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Health Qual Life Outcomes. 2019; 17(1): 165. doi.org/ 10.1186/s12955-019-1239-1.
8. Moreira DP. Simino GPR. Reis IA. Santos MA da C. Cherchiglia ML. Quality of life of patients with cancer undergoing chemotherapy in hospitals in Belo Horizonte, Minas Gerais State, Brazil: does individual characteristics matter? Cad Saude Publica. 2021; 37(8): e00002220. doi.org/ 10.1590/0102-311X00002220.
9. Gayatri D. Efremov L. Kantelhardt EJ. Mikolajczyk R. Quality of life of cancer patients at palliative care units in developing countries: systematic review of the published literature. Qual life Res an Int J Qual life Asp Treat care Rehabil. 2021; 30(2): 315–43. doi.org/ 10.1007/s11136-020-02633-z
10. Jayasinghe R. Fernando A. Jayarajah U. Seneviratne S. Post treatment quality of life among Sri Lankan women with breast cancer. BMC Cancer. 2021; 21(1): 305. doi.org. 10.1186/s12885-021-08055-5
11. Hassen AM. Taye G. Gizaw M. Hussien FM. Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. PLoS One. 2019; 14(9): e0222629. doi.org/ 10.1371/journal.pone.0222629.
12. Imran M. Al-Wassia R. Alkhayyat SS. Baig M. Al-Saati BA. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia. PLoS One. 2019; 14(7): e0219093. doi.org/ 10.1371/journal.pone.0219093.
13. Perwitasari DA. Atthobari J. Dwiprahasto I. Hakimi M. Gelderblom H. Putter H. et al. Translation and validation of EORTC QLQ-C30 into Indonesian version for cancer patients in Indonesia. Jpn J Clin Oncol. 2011; 41(4): 519–29. doi.org/ 10.1097/IGC.0b013e318234f9ee
14. Perwitasari DA. Atthobari J. Mustofa M. Dwiprahasto I. Hakimi M. Gelderblom H. et al. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer. Int J Gynecol Cancer. 2012; 22(1): 139–45. doi.org/ 10.1097/IGC.0b013e318234f9ee
15. Purba FD. Hunfeld JAM. Iskandarsyah A. Fitriana TS. Sadarjoen SS. Ramos-Goni JM. et al. The Indonesian EQ-5D-5L Value Set. Pharmacoeconomics. 2017; 35(11): 1153–65. doi.org/ 10.1007/s40273-017-0538-9.
16. Versteegh MM. Leunis A. Luime JJ. Boggild M. Uyl-de Groot CA. Stolk EA. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Med Decis Mak an Int J Soc Med Decis Mak. 2012; 32(4): 554–68. doi.org/ 10.1177/0272989X11427761.
17. Hagiwara Y. Shiroiwa T. Taira N. Kawahara T. Konomura K. Noto S. et al. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer. Health Qual Life Outcomes 2020; 18(1): 354. doi.org/ 10.1186/s12955-020-01611-w
18. Kontodimopoulos N. Aletras VH. Paliouras D. Niakas D. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2009; 12(8): 1151–7. doi.org/ 10.1111/j.1524-4733.2009.00569.x
19. Zafar S. Alexander SC. Weinfurt KP. Schulman KA. Abernethy AP. Decision making and quality of life in the treatment of cancer: a review. Support care cancer Off J Multinatl Assoc Support Care Cancer. 2009; 17(2): 117–27. doi.org/ 10.1007/s00520-008-0505-2
20. McKenzie L. van der Pol M. Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2009; 12(1): 167–71. doi.org/ 10.1111/j.1524-4733.2008.00405.x
21. Kim E Ju. Ko SK. Kang HY. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients. Qual life Res an Int J Qual life Asp Treat care Rehabil. 2012; 21(7): 1193–203. doi.org/ 10.1007/s11136-011-0037-y
22. Fayers P. Aaronson N. Bjordal K. Groenvold M. Curran D. Bottomley A. EORTC QLQ-C30 Scoring Manual [Internet]. EORTC Publ. Brussels2001 [cited 2020 Oct 18];Available from: https://www.eortc.org/app/uploads/sites/2/2018/02/SCmanual.pdf
23. Aaronson NK. Ahmedzai S. Bergman B. Bullinger M. Cull A. Duez NJ. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5): 365–76. doi.org/ 10.1007/s11136-011-9903-x.
24. Herdman M. Gudex C. Lloyd A. Janssen M. Kind P. Parkin D. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10): 1727–36. doi.org/ 10.1007/s11136-011-9903-x
25. Purba FD. Hunfeld JAM. Iskandarsyah A. Fitriana TS. Sadarjoen SS. Passchier J. et al. Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS One 2018;13(5): e0197098. doi.org/ 10.1371/journal.pone.0197098
26. Sari S. Andayani T. Endarti D. Widayati W. Health-Related Quality of Life in Non-Small Cell Lung Cancer (NSCLC) Patients with Mutation of Epidermal Growth Factor Receptor (EGFR) in Indonesia. Res J Pharm Tech. 2020; 13(1): 443–7. doi.org/ 10.2165/00129785-200505020-00006.
27. Gayatri D. Efremov L. Mikolajczyk R. Kantelhardt EJ. Quality of Life Assessment and Pain Severity in Breast Cancer Patients Prior to Palliative Oncology Treatment in Indonesia: A Cross-Sectional Study. Patient Prefer Adherence. 2021; 15: 2017–26. doi.org/ 10.2147/PPA.S320972
28. Setyowibowo H. Purba FD. Hunfeld JAM. Iskandarsyah A. Sadarjoen SS. Passchier J. et al. Quality of life and health status of Indonesian women with breast cancer symptoms before the definitive diagnosis: A comparison with Indonesian women in general. PLoS One. 2018; 13(7): e0200966. doi.org/ 10.1371/journal.pone.0200966
29. Lidgren M. Wilking N. Jönsson B. Rehnberg C. Health related quality of life in different states of breast cancer. Qual life Res an Int J Qual life Asp Treat care Rehabil. 2007;16(6):1073–81. doi.org/ 10.1007/s11136-007-9202-8
30. Rabin EG. Heldt E. Hirakata VN. Fleck MP. Quality of life predictors in breast cancer women. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc. 2008; 12(1): 53–7. doi.org/ 10.1016/j.ejon.2007.06.003
31. Ho PJ. Gernaat SAM. Hartman M. Verkooijen HM. Health-related quality of life in Asian patients with breast cancer: a systematic review. BMJ Open. 2018; 8(4): e020512. doi.org/ 10.1136/bmjopen-2017-020512
32. Kaur J. An Exploratory Study to Assess the Quality of Life among Cancer Patients of District Bathinda, Punjab. Asian J Nur Edu Res 2015; 5(1): 18–22. doi.org/ 10.5958/2349-2996.2015.00005.1
33. Versteegh MM. Rowen D. Brazier JE. Stolk EA. Mapping onto Eq-5 D for patients in poor health. Health Qual Life Outcomes. 2010; 8: 141. doi.org/ 10.1186/1477-7525-8-141
34. Ecclestone C. Chow R. Pulenzas N. Zhang L. Leahey A. Hamer J. et al. Quality of life and symptom burden in patients with metastatic breast cancer. Support care cancer Off J Multinatl Assoc Support Care Cancer. 2016; 24(9): 4035–43. doi.org/ 10.1007/s00520-016-3217-z
35. Schmidt ME. Wiskemann J. Armbrust P. Schneeweiss A. Ulrich CM. Steindorf K. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. Int J Cancer. 2015; 137(2): 471–80. doi.org/10.1002/ijc.29383.
36. Kim SH. Jo MW. Kim HJ. Ahn JH. Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients. Health Qual Life Outcomes. 2012; 10: 151. doi.org/10.1186/1477-7525-10-151
37. Vijaya Lakshmi D. Asha K. Mounika B. Babu K. An Evaluation of quality of life in patients on concurrent Chemo radiotherapy with Cisplatin in Head and Neck Cancer- A Prospective Observational Study. Int J Curr Adv Res. 2018; 7(1B): 8815-21. http://dx.doi.org/10.24327/ijcar.2018.8821.1435
38. Amanova A. Abassova G. Kaishibayeva G. Kovalchuk V. Quality of Life of Patients with Neurological Conditions and Neuropathic Pain. Res J Pharm Tech. 2018; 11(2): 504–8. doi.org/ 10.5958/0974-360X.2018.00092.6
39. Pan HT. Wu LM. Wen SH. Quality of Life and Its Predictors Among Children and Adolescents With Cancer. Cancer Nurs. 2017;40(5):343–51. doi.org/10.1097/NCC.0000000000000433.
40. Sampoornam W. Emotional Support Improves Quality of Life in Women Undergoing Radiation Therapy for Breast Cancer - A Wait List Control Arm. Asian J Nur Edu Res. 2015; 5(3): 318–318. doi.org/ 10.5958/2349-2996.2015.00064.6
41. Gnanarani J. Venkatesan L. The Palliative Care Needs, Quality Of Life and Coping Strategies among Oncology Patients And End Stage Organ Disease. Asian J Nur Edu Res. 2016; 6(3): 371–6. doi.or/ 10.5958/2349-2996.2016.00069.0
42. Geetha M. Padmavathi P. Menaka K. Effectiveness of Multi Interventional Package on Quality of Life among Breast Cancer Patients Receiving Chemotherapy Drugs – Pilot Study. Int J Adv Nur Manag. 2017; 5(2): 164–8. doi.org/ 10.5958/2454-2652.2017.00035.X
43. Kavitha S. Vaidyanathan R. Vijayaraghavan. A study to assess the effectiveness of care bundle approach on the level of chemotherapy induced peripheral neuropathy and quality of life among patients receiving neurotoxic chemotherapy. Res J Pharm Tech. 2018; 10(4): 179–99. doi.org/ 10.5958/2321-5836.2018.00033.2